Dermatology Department, Complejo Hospitalario Universitario de Toledo, Toledo, Spain.
Escuela Internacional de Doctorado, Universidad de Castilla-La-Mancha, Toledo, Spain.
Contact Dermatitis. 2024 Nov;91(5):379-386. doi: 10.1111/cod.14675. Epub 2024 Aug 20.
Reports of allergic contact dermatitis (ACD) to phytonadione epoxide (PE) in cosmetics suggest that PE is as powerful a sensitiser as its parent compound phytonadione.
To evaluate a case series of ACD to PE in Spain.
We reviewed the records of 20 patients with ACD to cosmetics containing PE diagnosed across Spain between January 2019 and June 2023.
All 20 patients developed patch test (PT) or repeated open application test (ROAT) reactions to cosmetics containing PE. All involved women with eyelid eczema. PT or ROAT with PE preparations were positive in 17/20 (85%). PE at 1%, 5%, 10% and 20% in pet. was patch-tested in 8/17, 14/17, 11/17 and 8/17 patients; being positive in 6/8 (75%), 13/14 (92.85%), 11/11 (100%) and 8/8 (100%), respectively.
Regulators should, not only ban the specific dangerous cosmetic ingredients, but also consider to ban or keep under close surveillance those closely related products or derivatives that might potentially cause similar harmful effects. PTs with PE are suggested to be performed at a 5% concentration in pet. Higher concentrations (10% pet.) should be tested whenever PTs with 5% pet. PE are negative.
化妆品中叶绿醌环氧化物(PE)引起的过敏性接触性皮炎(ACD)报告表明,PE 与其母体化合物叶绿醌一样具有致敏作用。
评估西班牙一组 PE 致 ACD 的病例系列。
我们回顾了 2019 年 1 月至 2023 年 6 月期间在西班牙诊断为含 PE 的化妆品致 ACD 的 20 例患者的记录。
所有 20 例患者均对含 PE 的化妆品发生了斑贴试验(PT)或重复开放应用试验(ROAT)反应。所有患者均为女性,患有眼睑湿疹。17/20(85%)例患者的 PE 制剂 PT 或 ROAT 阳性。8/17、14/17、11/17 和 8/17 例患者分别进行了 1%、5%、10%和 20% PE 于豚鼠的斑贴试验;阳性率分别为 6/8(75%)、13/14(92.85%)、11/11(100%)和 8/8(100%)。
监管机构不仅应禁止特定的危险化妆品成分,还应考虑禁止或密切监测那些可能具有类似有害影响的密切相关产品或衍生物。建议在 5%的豚鼠中进行 PE 的 PT。如果 5%的 PE 豚鼠 PT 为阴性,则应测试 10%的豚鼠。